• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov9
ALX Oncology Reports Strong Clinical Results in Q3 Earnings Call
00:26
Nov7
ALX Oncology released FY2025 9 Months Earnings on November 7 Pre-Market EST with actual revenue of USD 0 and EPS of USD -1.4751
14:30
ALX Oncology released FY2025 Q3 earnings on November 7 Pre-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4133 (forecast USD -0.3725)
14:30
Oct31
ALX Oncology to Release FY2025 Q3 Earnings on November 7, 2025 Pre-Market EST, Forecast EPS -0.3725 USD
00:11
Oct23
ALX Oncology Holdings Initiates Phase I Clinical Trial of ALX2004
16:30
Aug12
ALX Oncology released FY2025 Q2 earnings on August 12 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4855 (forecast USD -0.4506)
23:00

Schedules & Filings

Schedules
Filings
Nov7
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -22.14 M, EPS -0.4133

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.95 M, EPS -0.4855

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -30.75 M, EPS -0.5763

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
GURE
9.400
+98.31%
+4.660
WHLR
6.170
+90.43%
+2.943
SMX
226.547
+60.67%
+91.700
TDIC
0.4123
+46.83%
+0.130
PAVS
0.0460
+46.03%
+0.015
IRBT
4.413
+45.65%
+1.414
PRAX
264.810
+39.40%
+74.840
TGL
9.270
+37.17%
+2.512
TORO
5.500
+33.17%
+1.410
AKAN
1.210
+27.89%
+0.264
View More